Therapeutic Drug Monitoring rapid test for Adalimumab - now available from R-biopharm

RIDA^®QUICK ADM Monitoring is now available and allows a fast and reliable decision making in regards to therapy adaption.

RIDA^®QUICK ADM Monitoring Read more

Flyer "Need for IFX and ADM rapid testing?"

Influence of early adalimumab serum levels on immunogenicity and long‐term outcome of anti‐TNF naive Crohn's disease patients: the usefulness of rapid testing

Contact us for more information